Lipidomics studies on macrophages - RAW 264.7 cells treated with Kdo2-Lipid A and compactin

Introduction | Browse | Search | Download
Mouse-over the above links for more information

Treatment details

LM ID Analyte Treatment Time(hrs) Sample ID Value Units
LMFA03050011 8-HETrE cPLA2i 1.0 BCD110605C28 0.069 pmol/ml medium
LMFA03050011 8-HETrE cPLA2i 1.0 BCD110605C30 0.081 pmol/ml medium
LMFA03050011 8-HETrE cPLA2i 1.0 BCD110605C29 0.07 pmol/ml medium
LMFA03050011 8-HETrE cPLA2i 20.0 BCD110605C64 0.122 pmol/ml medium
LMFA03050011 8-HETrE cPLA2i 20.0 BCD110605C66 0.105 pmol/ml medium
LMFA03050011 8-HETrE cPLA2i 20.0 BCD110605C65 0.12 pmol/ml medium
LMFA03050011 8-HETrE PLDi 1.0 BCD110605C16 0.083 pmol/ml medium
LMFA03050011 8-HETrE PLDi 1.0 BCD110605C17 0.059 pmol/ml medium
LMFA03050011 8-HETrE PLDi 1.0 BCD110605C18 0.066 pmol/ml medium
LMFA03050011 8-HETrE PLDi 20.0 BCD110605C54 0.138 pmol/ml medium
LMFA03050011 8-HETrE PLDi 20.0 BCD110605C52 0.178 pmol/ml medium
LMFA03050011 8-HETrE PLDi 20.0 BCD110605C53 0.17 pmol/ml medium
LMFA03050011 8-HETrE KDO+cPLA2i 1.0 BCD110605C32 0.088 pmol/ml medium
LMFA03050011 8-HETrE KDO+cPLA2i 1.0 BCD110605C31 0.063 pmol/ml medium
LMFA03050011 8-HETrE KDO+cPLA2i 1.0 BCD110605C33 0.073 pmol/ml medium
LMFA03050011 8-HETrE KDO+cPLA2i 20.0 BCD110605C68 0.101 pmol/ml medium
LMFA03050011 8-HETrE KDO+cPLA2i 20.0 BCD110605C69 0.092 pmol/ml medium
LMFA03050011 8-HETrE KDO+cPLA2i 20.0 BCD110605C67 0.1 pmol/ml medium
LMFA03050011 8-HETrE KDO+PLDi 1.0 BCD110605C19 0.049 pmol/ml medium
LMFA03050011 8-HETrE KDO+PLDi 1.0 BCD110605C20 0.067 pmol/ml medium
LMFA03050011 8-HETrE KDO+PLDi 1.0 BCD110605C21 0.07 pmol/ml medium
LMFA03050011 8-HETrE KDO+PLDi 20.0 BCD110605C56 0.09 pmol/ml medium
LMFA03050011 8-HETrE KDO+PLDi 20.0 BCD110605C57 0.1 pmol/ml medium
LMFA03050011 8-HETrE KDO+PLDi 20.0 BCD110605C55 0.101 pmol/ml medium
LMFA03050011 8-HETrE KDO+ATP+cPLA2i 1.0 BCD110605C37 0.069 pmol/ml medium
LMFA03050011 8-HETrE KDO+ATP+cPLA2i 1.0 BCD110605C38 0.068 pmol/ml medium
LMFA03050011 8-HETrE KDO+ATP+cPLA2i 1.0 BCD110605C39 0.058 pmol/ml medium
LMFA03050011 8-HETrE KDO+ATP+cPLA2i 20.0 BCD110605C74 0.089 pmol/ml medium
LMFA03050011 8-HETrE KDO+ATP+cPLA2i 20.0 BCD110605C75 0.068 pmol/ml medium
LMFA03050011 8-HETrE KDO+ATP+cPLA2i 20.0 BCD110605C73 0.064 pmol/ml medium
LMFA03050011 8-HETrE KDO+ATP+PLDi 1.0 BCD110605C25 0.064 pmol/ml medium
LMFA03050011 8-HETrE KDO+ATP+PLDi 1.0 BCD110605C27 0.066 pmol/ml medium
LMFA03050011 8-HETrE KDO+ATP+PLDi 1.0 BCD110605C26 0.053 pmol/ml medium
LMFA03050011 8-HETrE KDO+ATP+PLDi 20.0 BCD110605C61 0.063 pmol/ml medium
LMFA03050011 8-HETrE KDO+ATP+PLDi 20.0 BCD110605C62 0.049 pmol/ml medium
LMFA03050011 8-HETrE KDO+ATP+PLDi 20.0 BCD110605C63 0.042 pmol/ml medium
LMFA03050011 8-HETrE KDO + ATP 1.0 BCD110605C15 0.059 pmol/ml medium
LMFA03050011 8-HETrE KDO + ATP 1.0 BCD110605C14 0.057 pmol/ml medium
LMFA03050011 8-HETrE KDO + ATP 1.0 BCD110605C13 0.074 pmol/ml medium
LMFA03050011 8-HETrE KDO + ATP 20.0 BCD110605C49 0.067 pmol/ml medium
LMFA03050011 8-HETrE KDO + ATP 20.0 BCD110605C50 0.066 pmol/ml medium
LMFA03050011 8-HETrE KDO + ATP 20.0 BCD110605C51 0.055 pmol/ml medium
LMFA03050011 8-HETrE KDO 1.0 BCD110605C08 0.044 pmol/ml medium
LMFA03050011 8-HETrE KDO 1.0 BCD110605C07 0.049 pmol/ml medium
LMFA03050011 8-HETrE KDO 1.0 BCD110605C09 0.051 pmol/ml medium
LMFA03050011 8-HETrE KDO 20.0 BCD110605C45 0.103 pmol/ml medium
LMFA03050011 8-HETrE KDO 20.0 BCD110605C44 0.122 pmol/ml medium
LMFA03050011 8-HETrE KDO 20.0 BCD110605C43 0.094 pmol/ml medium
LMFA03050011 8-HETrE C 0.0 BCD110605C03 0.047 pmol/ml medium
LMFA03050011 8-HETrE C 0.0 BCD110605C01 0.06 pmol/ml medium